News | October 24, 2007

Cardiologists Perform Percutaneous Revalving Procedure Live at TCT

October 24, 2007 – During a live demonstration at TCT 2007 of CoreValve’s 18-French ReValving System for percutaneous aortic valve replacement (PAVR), cardiologists performed the implantation of the device in a high-risk patient suffering from Chronic Obstructive Pulmonary Disease (COPD).

CoreValve’s third-generation aortic heart valve was implanted successfully and non-surgically in a patient suffering from COPD, using its percutaneous, 18-French ReValving System. Eberhard Grube, M.D., and Ulrich Gerckens, M.D., of the HELIOS Heart Center, Siegburg, Germany, performed the revalving procedure live via satellite television from their hospital’s cath lab for an audience comprised of cardiologists, cardiovascular surgeons and industry executives.

“This was the 158th revalving procedure within the scope of our post-CE Mark Expanded Evaluation registry. When combined with the results of 191 previous cases of the feasibility, safety and efficacy trials, it demonstrates that interventional cardiology treatment of structural heart disease is no longer just a hope for the future but a reality today that provides a new treatment option for high-risk and inoperable patients,” said Jacques Séguin, M.D., Ph.D., Chairman, CEO and Founder of CoreValve.

For more information: www.corevalve.com

Related Content

Edwards LifeSciences Recalls Sapien 3 Certitude Delivery System
News | Heart Valve Technology| January 11, 2018
The U.S. Food and Drug Administration (FDA) announced that Edwards LifeSciences is recalling its Certitude Delivery...
Videos | Heart Valve Technology| January 04, 2018
Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how hi
Edwards Acquires Harpoon Medical
News | Heart Valve Technology| December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Videos | Heart Valve Technology| November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology| November 08, 2017
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut...
Videos | Heart Valve Technology| November 08, 2017
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the
Videos | Heart Valve Technology| November 08, 2017
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morris
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology| November 07, 2017
November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and c
Videos | Heart Valve Technology| November 07, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state o
Overlay Init